Pioneer Fund

Pioneer Fund is a venture capital firm founded in 2017, with its headquarters in Toronto, Canada. The firm focuses on early-stage investments and is particularly tied to the Y Combinator network, comprising over 420 alumni from the accelerator program. Pioneer Fund targets a diverse range of sectors, including consumer products, financial services, information technology, advanced manufacturing, blockchain, life sciences, gaming, artificial intelligence, and education technology, among others. By leveraging its connection to Y Combinator, Pioneer Fund aims to support innovative startups with high growth potential across various industries.

Amitav Chakravartty

Venture Partner

Bryant Chou

Senior Venture Partner

Mike Dilworth

CFO and General Partner

Jason Gray

Founder and Managing General Partner

Ranvir Gujral

Venture Partner

Beth Kolko

Senior Venture Partner

Evan Lodge

Venture Partner

Parthi Loganathan

Venture Partner

Matthew McDonald

Venture Partner

Dave Messina

General Partner

Victor Ng

Venture Partner

Eric Norman

Visiting General Partner

Will Olsen

Venture Partner

Alexander Strunkin

Venture Partner

Jonathan Tang

Senior Venture Partner

Kitch Wilson

Venture Partner

Past deals in Nigeria

54gene

Series A in 2020
54gene is a healthcare company founded in 2019 by Dr. Abasi Ene-Obong, focused on advancing genomic research in Africa. Headquartered in San Francisco with an office in Lagos, Nigeria, the company aims to address the underrepresentation of African genetic data in pharmaceutical research, where only 2% of genetic material used is from African populations. By developing a pan-African biobank, 54gene seeks to identify new drug targets and create diagnostics and treatments for various diseases, including cancer, cardiovascular, and neurodegenerative diseases. Additionally, the company offers genetic testing and molecular diagnostics services to enhance understanding of the human genome and improve access to essential healthcare solutions.

54gene

Seed Round in 2019
54gene is a healthcare company founded in 2019 by Dr. Abasi Ene-Obong, focused on advancing genomic research in Africa. Headquartered in San Francisco with an office in Lagos, Nigeria, the company aims to address the underrepresentation of African genetic data in pharmaceutical research, where only 2% of genetic material used is from African populations. By developing a pan-African biobank, 54gene seeks to identify new drug targets and create diagnostics and treatments for various diseases, including cancer, cardiovascular, and neurodegenerative diseases. Additionally, the company offers genetic testing and molecular diagnostics services to enhance understanding of the human genome and improve access to essential healthcare solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.